TEGSEDI: The Right Time Is Now

A product campaign for patients

Patients experiencing the polyneuropathy of hereditary ATTR amyloidosis slowly lose nerve and motor function, greatly impacting their daily lives.

The campaign boasts TEGSEDI’s powerful knockdown of unwanted proteins, confidence in treatment through routine monitoring, and independence for patients, who can self-administer TEGSEDI at the time and place that’s right for them.